Epigallocatechin Gallate: Advanced Ophthalmic Formulation for Dry Eye Syndrome Treatment
Discover the innovative use of Epigallocatechin Gallate within a biodegradable hydrogel for effective dry eye syndrome management, offering sustained release and enhanced therapeutic benefits.
Get a Quote & SampleProduct Core Value
Epigallocatechin Gallate
As a leading supplier in China, we offer Epigallocatechin Gallate (EGCG), a powerful polyphenol derived from green tea. Our EGCG is expertly encapsulated within a novel gelatin-g-poly(N-isopropylacrylamide) (GN) hydrogel, creating a revolutionary ophthalmic formulation. This advanced system is designed for the topical treatment of dry eye syndrome (DED), providing sustained release of EGCG to enhance its natural anti-inflammatory and antioxidant properties. This breakthrough formulation offers superior therapeutic efficacy compared to conventional eye drops, making us a trusted manufacturer in delivering advanced healthcare solutions.
- Leveraging advanced ophthalmic formulation development, we provide EGCG-loaded GN carriers that ensure sustained release of the active compound, crucial for prolonged therapeutic effect in dry eye conditions.
- Our commitment as a supplier in China means you receive high-quality Epigallocatechin Gallate, rigorously tested for purity and efficacy in our innovative drug delivery systems.
- The biodegradable nature of our GN hydrogel system ensures patient comfort and minimizes potential long-term ocular side effects, a key advantage in ophthalmic treatment.
- We facilitate efficient EGCG delivery, crucial for tackling ocular inflammation and oxidative stress, core issues in the progression of dry eye syndrome, ensuring optimal patient outcomes.
Advantages Provided by the Product
Enhanced Therapeutic Efficacy
The sustained release of EGCG from our biodegradable hydrogel system significantly boosts its anti-inflammatory and antioxidant effects, crucial for managing dry eye symptoms and preventing further ocular damage.
Improved Patient Compliance
The in situ gelling nature of the formulation allows for convenient single-dose application, improving patient compliance and reducing the need for frequent eye drop instillation, a key benefit in treating chronic conditions like dry eye.
Superior Biocompatibility
Extensive in vitro and in vivo studies confirm the excellent biocompatibility of our GN carriers, ensuring minimal irritation and a safe profile for ophthalmic use, a critical factor for any ocular treatment.
Key Applications
Ophthalmology
Our Epigallocatechin Gallate formulation is specifically designed for ophthalmic applications, targeting the treatment of Dry Eye Syndrome through advanced drug delivery.
Dry Eye Treatment
The potent anti-inflammatory and antioxidant properties of EGCG, delivered via our sustained-release hydrogel, offer a novel and effective approach to alleviate the symptoms and progression of Dry Eye Syndrome.
Ocular Drug Delivery
This innovation represents a significant advancement in ocular drug delivery, utilizing biodegradable in situ gelling systems to improve the bioavailability and therapeutic outcomes of topical ocular medications.
Anti-inflammatory Therapies
Beyond dry eye, the anti-inflammatory capabilities of EGCG delivered through our formulation hold potential for other ocular inflammatory conditions, making it a versatile therapeutic agent.